“We are in the golden age of science and technology, advancements in gene editing and ASO therapies are allowing doctors to deliver targeted, and in some cases one-time, interventions for conditions once considered untreatable. A conversation with Harvard Medical School Professor Dr. Anna Greka and n-Lorem Foundation Chairman & CEO Dr. Stan Crooke about what this means for millions of patients now and in the future.”
Watch the conversation from the CNBC Cures Summit here.